250 related articles for article (PubMed ID: 16616063)
1. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
Calin GA; Croce CM
Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
Calin GA; Pekarsky Y; Croce CM
Best Pract Res Clin Haematol; 2007 Sep; 20(3):425-37. PubMed ID: 17707831
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
Nana-Sinkam SP; Croce CM
Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
[TBL] [Abstract][Full Text] [Related]
4. New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U; Dalla-Favera R
Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
[TBL] [Abstract][Full Text] [Related]
5. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
6. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
[TBL] [Abstract][Full Text] [Related]
7. miR-15 and miR-16 induce apoptosis by targeting BCL2.
Cimmino A; Calin GA; Fabbri M; Iorio MV; Ferracin M; Shimizu M; Wojcik SE; Aqeilan RI; Zupo S; Dono M; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13944-9. PubMed ID: 16166262
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.
Nicoloso MS; Kipps TJ; Croce CM; Calin GA
Br J Haematol; 2007 Dec; 139(5):709-16. PubMed ID: 18021085
[TBL] [Abstract][Full Text] [Related]
10. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?
Caligaris-Cappio F; Ghia P
J Clin Oncol; 2008 Sep; 26(27):4497-503. PubMed ID: 18662968
[TBL] [Abstract][Full Text] [Related]
11. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
Calin GA; Ferracin M; Cimmino A; Di Leva G; Shimizu M; Wojcik SE; Iorio MV; Visone R; Sever NI; Fabbri M; Iuliano R; Palumbo T; Pichiorri F; Roldo C; Garzon R; Sevignani C; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
N Engl J Med; 2005 Oct; 353(17):1793-801. PubMed ID: 16251535
[TBL] [Abstract][Full Text] [Related]
12. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
[TBL] [Abstract][Full Text] [Related]
13. All you need is a Mir-acle: the role of nontranslated RNAs in the suppression of B cell chronic lymphocytic leukemia.
Lichter P
Cancer Cell; 2010 Jan; 17(1):3-4. PubMed ID: 20129242
[TBL] [Abstract][Full Text] [Related]
14. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
15. c-Abl expression in chronic lymphocytic leukemia cells: clinical and therapeutic implications.
Lin K; Glenn MA; Harris RJ; Duckworth AD; Dennett S; Cawley JC; Zuzel M; Slupsky JR
Cancer Res; 2006 Aug; 66(15):7801-9. PubMed ID: 16885384
[TBL] [Abstract][Full Text] [Related]
16. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
[TBL] [Abstract][Full Text] [Related]
17. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
[TBL] [Abstract][Full Text] [Related]
18. Familial chronic lymphocytic leukemia.
Sellick GS; Catovsky D; Houlston RS
Semin Oncol; 2006 Apr; 33(2):195-201. PubMed ID: 16616066
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes.
Plass C; Byrd JC; Raval A; Tanner SM; de la Chapelle A
Br J Haematol; 2007 Dec; 139(5):744-52. PubMed ID: 17961188
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in chronic lymphocytic leukemia.
Ward BP; Tsongalis GJ; Kaur P
Exp Mol Pathol; 2011 Apr; 90(2):173-8. PubMed ID: 21168405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
